Stay updated with breaking news from Ftre. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Fortrea (NASDAQ:FTRE – Get Free Report) and Biodesix (NASDAQ:BDSX – Get Free Report) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, dividends, valuation, earnings, analyst recommendations, risk and institutional ownership. Analyst Recommendations This is a breakdown of current ratings and […] ....
Fortrea (NASDAQ:FTRE – Get Free Report) and Invitae (NYSE:NVTA – Get Free Report) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, earnings, profitability, risk, institutional ownership, analyst recommendations and dividends. Analyst Ratings This is a summary of current ratings for […] ....
Citigroup upgraded shares of Fortrea (NASDAQ:FTRE – Free Report) from a neutral rating to a buy rating in a report issued on Monday morning, Marketbeat reports. Citigroup currently has $40.00 price objective on the stock, up from their previous price objective of $34.00. A number of other research analysts also recently commented on FTRE. Barclays […] ....
Fortrea (NASDAQ:FTRE – Free Report) had its target price reduced by Evercore ISI from $31.00 to $30.00 in a report issued on Wednesday, FlyOnTheWall reports. A number of other brokerages have also weighed in on FTRE. Bank of America assumed coverage on Fortrea in a research report on Monday, August 7th. They issued an underperform […] ....